Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats

Table 4 Effect of MCDD alone or enriched with different fats on fatty acids percentage in the liver

Fatty acids components	Control	MCDD	MCDD + olive oil	MCDD + fish oil	MCDD + butter	1P	2P
						(Friedman test)
C14:0 Myristic	0.2 ± 0.2	0.5 ± 0.1	0.3 ± 0.2	0.4 ± 0.2	0.4 ± 0.2	0.003	0.002
C16:0 Palmitic	19 ± 1	17 ± 1.1	15.3 ± 1.4ac	15.5 ± 1.1	15.7 ± 2.3	0.001	0.006
C16:1 Palmitoleic	0.1 ± 0.2	0.7 ± 0.1	0.4 ± 0.2	0.7 ± 0.1	0.4 ± 0.2	0.007	0.02
C18:0 Stearic	21.8 ± 1.6	5.8 ± 0.6	5.7 ± 0.7ac	6.2 ± 0.5	6.1 ± 0.9	0.002	0.01
C18:1n9t Elaidic	2.1 ± 0.1	1.5 ± 1.3	22.8 ± 1.3	17.8 ± 1.1	21.3 ± 1.1	0.001	0.006
C18:1n9c Oleic	4.9 ± 0.8	20.7 ± 0.7	25.9 ± 3.3ac	2.0 ± 0.1	5.3 ± 8.7	0.001	0.006
C18:2n6c Linolelaidic	18.6 ± 1.8	32.4 ± 0.7	30.5 ± 1.7ac	29.5 ± 2.1	31.5 ± 2.1	0.001	0.006
C18:3n3 Linolenic	0.5 ± 0.3	0.3 ± 0.1	0.2 ± 0.2c	0.2 ± 0.2	0.3 ± 0.2	0.007	0.02
C23:0 Tricosanoic	22.0 ± 2.4	10.0 ± 1.1	7.8 ± 2.1ac	0	0	0.003	0.02
C20:4n6 Arachidonic	0.1 ± 0.2	0	9.2 ± 0.6ac	6.5 ± 0.6	9.7 ± 1.2	0.002	0.006
C22:6n3 Docosahexaenoic	4.5 ± 0.9	1.3 ± 0.5	1.2 ± 0.4	9.0 ± 1.2	1.1 ± 0.6	0.006	0.01
C20:5n3 Eicosapentaenoic	0	0.1 ± 0.1	0	0.9 ± 0.1	0	0.003	0.002

¹Comparison between MCDD and treatment groups; ²comparison between the three treatment groups.

^aP < 0.02 vs MCDD + fish oil;

^cP < 0.02 vs MCDD + butter group.